Ha Ha ... my post really seems to have stirred the nest.
To be quite frank, I was getting a little tired of the many people posting that they would jump at $50 if it was on the table tomorrow.
My post was really to demonstrate one practical model that would result in a share price above $50.
As you can see in my model the end game was for a Big Pharma to take out both NEU and Acadia in a step phase process, with at each stage a 1.5 times moderate uplift. Quite a reasonable model without getting too carried away.
My goals are very simple and have always been that way when I invest in biotech companies more than any other industry:
- I really like investing in companies where the outcomes provide goodness to people - those suffering, their families and care givers
- The biotech companies have a strong Board, Senior Mgt Team, Researchers & Advisory Team that "do what they say they will do"
- The companies stay true to its goals and continues to deliver whilst dealing with the challenges along the way in their stride
- A company that respects it target audience (patients) and the wide variety of shareholders - maximises $$$$ spent on its programs
- Delivers the outcomes with modesty and pride.
For me, my investment in NEU in reflected in these statements.
I really don't mind who takes control of NEU as long as they show a similar dedication to the cause of improving the lives of those suffering.
Wonderful year in 2023 and I am confident the good news will continue into an exciting 2024 and beyond.
Happy New Year
GLTA
- Forums
- ASX - By Stock
- NEU
- Market Capitalisation is a Better Valuation Metric Than Share Price
Market Capitalisation is a Better Valuation Metric Than Share Price, page-94
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.00 |
Change
-0.010(0.05%) |
Mkt cap ! $2.681B |
Open | High | Low | Value | Volume |
$20.87 | $21.19 | $20.82 | $2.558M | 121.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 26 | $20.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.00 | 80 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 104 | 20.980 |
4 | 116 | 20.970 |
8 | 335 | 20.960 |
2 | 194 | 20.950 |
5 | 282 | 20.940 |
Price($) | Vol. | No. |
---|---|---|
21.000 | 133 | 4 |
21.010 | 266 | 4 |
21.020 | 199 | 2 |
21.030 | 197 | 2 |
21.040 | 205 | 2 |
Last trade - 13.46pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
$20.91 |
  |
Change
-0.010 ( 0.36 %) |
|||
Open | High | Low | Volume | ||
$20.99 | $21.19 | $20.82 | 60583 | ||
Last updated 14.02pm 21/05/2024 ? |
Featured News
NEU (ASX) Chart |